Cidara Therapeutics to Present New Analyses for Rezafungin at the 31st European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)

NEXT STORY
TRACON Pharmaceuticals Announces Appointment of Ya Huang as Executive Director of Statistical Programming and Granting of Inducement Award
PREV STORY
Global Smart Surfaces Market Research Report 2021: Self-Healing, Self-Sensing and Self-Cleaning Materials Poised to Transform Construction Sector
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharmaceuticals Brilacidin Oral Mucositis Program Moving Forward Based Upon Positive Anchoring Phase 2 Results and Increased Brilacidin Franchise Value

BEVERLY, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a ...

author_avatar
NASDAQ Market News

Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis

author_avatar
NASDAQ Market News

Home Infusion Therapy Market Size & Share Will Reach USD 27.95 Billion by 2022: Zion Market Research

Sarasota, FL, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a ...

author_avatar
NASDAQ Market News